Evom Secures $1M for Cardiology AI

In January 2026, the South Korean medical technology startup Evom was selected for the TIPS Deep Tech program by the Ministry of SMEs and Startups. The company will receive approximately $1 million (1.5 billion KRW) in R&D funding over the next three years to accelerate its cardiology-focused diagnostic engine.

The company is led by CEO Nam Hyeon-seob. Evom is tackling the “interpretation gap” in cardiovascular care by building a platform that automates the analysis of electrocardiograms (ECG) and echocardiograms.

Traditional cardiac diagnostics are often reactive and prone to human error. Evom addresses this by training proprietary models on massive datasets to detect subtle anomalies before they manifest as critical events. This transition from manual review to autonomous AI-driven observability allows for real-time risk stratification and precise clinical alerts.

The new capital will be used to advance its multimodal AI engine, which synchronizes ECG and ultrasound data. This move toward preventative, data-driven medicine mirrors the shift seen in predictive maintenance systems for heavy industry—where the goal is to identify failure points before they occur.

Market Signal

• The “Outcome-Based” Pivot: This funding validates a trend where medical AI is moving beyond simple image labeling to “outcome prediction.” Investors are shifting capital toward platforms that can fundamentally alter the clinical trajectory of high-net-worth patient populations.
• Government-Validated Alpha: Selection for the TIPS Deep Tech track acts as a major institutional moat. It signals that Evom possesses a level of algorithmic complexity and data fidelity that generic health apps cannot match.
• Vertical Data Dominance: Much like how autonomous SRE platforms handle complex system logs, Evom’s specialized data capture creates a defensible “biological moat.” By controlling the high-fidelity loop between medical sensors and diagnostics, Evom is positioning itself as the essential middleware for the cardiology ward.

Key Details

• Company: Evom
• Funding: $1M (TIPS Deep Tech R&D)
• Headquarters: Seoul, South Korea
• Lead Investor: Ministry of SMEs and Startups (TIPS)
• CEO: Nam Hyeon-seob
• Use Case: AI-powered early cardiac diagnosis and preventative heart care